在细胞中直接合成EM-可见金纳米颗粒，用于蛋白质定位分析，具有保存完好的超微结构
April 28th, 2023
本协议描述了一种可克隆的电子显微镜标记技术，用于使用基于新型自成核抑制机制的金纳米颗粒合成技术检测细胞中的金属硫蛋白标记蛋白。
蛋白质检测和定位在生物学研究中至关重要。我们的协议描述了一种使用基因编码标签的新型EM标记技术，该技术允许具有保存完好的超微结构的单分子原位可视化。避免过度固定至关重要。
标记方法基于标签中半胱氨酸的活性，半胱氨酸对醛交联高度敏感。我们的方案避免使用醛固定剂，并保留标签活性和超微结构。与此同时。
EM标记一直具有挑战性，存在形态不良或标记效率低下的问题。我们的方案直接在单个蛋白质上原位合成纳米颗粒，以提供目标蛋白质的清晰和精确定位，具有高信噪比、高效率和特异性。到目前为止，我们已经在分离的蛋白质、大肠杆菌细胞、酵母细胞和HeLa细胞中实现了出色的标记。
我们将探索和优化应用于组织样品的方法。结合流行的冷冻FIB和冷冻电镜技术将使我们能够解决重要的生物学问题。
View the full transcript and gain access to thousands of scientific videos
概述
本研究提出了一种新型电子显微镜（EM）标记技术，旨在检测细胞内的金属硫蛋白标记蛋白。该方法利用了一种抑制自发核化的机制，允许在保持细胞超微结构的同时进行精确的单分子可视化。
研究的主要组成部分
研究领域
- 细胞生物学
- 显微镜学
- 蛋白质定位和检测
背景
- 检测和定位蛋白质对于各种生物学研究应用至关重要。
- 传统的EM标记方法往往会影响形态和效率。
- 基因编码的标签可以提高蛋白质检测的灵敏度和特异性。
使用的方法
- 一种新型EM标记技术，避免使用醛类固定剂以保护蛋白质活性。
- 应用于分离的蛋白质、大肠杆菌、Easter细胞和HeLa细胞。
- 结合冷冻FIB和冷冻电子显微镜技术以增强成像。
主要结果
- 成功在单个蛋白质上直接合成金纳米粒子。
- 实现了高信噪比的清晰精确定位。
- 在各种生物样品中验证了该方法的效率和特异性。
结论
- 本研究展示了蛋白质检测技术的重大进展。
- 该方法有望解决分子水平的关键生物学问题。
常见问题
Executive Industry Relevance
Precise protein localization at ultrastructural resolution is a critical inflection point for target validation and mechanistic de-risking in early discovery. The direct synthesis of EM-visible gold nanoparticles on genetically encoded tags enables single-molecule visualization in situ, supporting predictive confidence for target engagement and pathway mapping. This capability strengthens translational continuity from discovery through preclinical research by preserving native cellular architecture.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables high-resolution mapping of protein localization to clarify target biology.
- Supports functional validation of engineered tags in both prokaryotic and eukaryotic systems.
- Facilitates mechanistic de-risking by preserving ultrastructure during detection.
- Improves predictive confidence for target engagement and pathway assignment.
Screening & Assay Development
- Provides robust, reproducible labeling for quantitative protein detection in cell-based assays.
- Standardizes EM probe generation using clonable tags for scalable workflows.
- Delivers high signal-to-noise outputs, enabling reliable compound evaluation in screening campaigns.
- Prepares validated biological systems for downstream EM-based analyses.
Translational & Preclinical Research
- Aligns protein localization data with disease-relevant ultrastructural contexts.
- Supports continuity from single-cell discovery to tissue-level preclinical validation.
- Enables risk-adjusted advancement decisions by providing ultrastructural evidence of target engagement.
- Facilitates biomarker alignment through precise subcellular mapping.
Pipeline & Workflow Integration
This EM labeling technology integrates from early discovery through lead identification and preclinical research, supporting hypothesis testing and mechanistic validation.
- Discovery Biology: Advances hypothesis-driven interrogation of protein function and localization in native cellular environments.
- Screening: Delivers reproducible, quantitative EM readouts for assay development and compound triage.
- Analytics: Provides high-efficiency, high-specificity nanoparticle labeling for comparative condition analysis.
- Translational Research: Bridges single-molecule detection with ultrastructural disease models for biomarker validation.
- Enterprise Reuse: Establishes a platform for standardized EM probe generation across diverse R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of EM-based protein detection.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by providing ultrastructural evidence.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of discovery assets.
Implementation Considerations
- Requires expertise in EM sample preparation and genetically encoded tag design.
- Needs access to high-pressure freezing, freeze-substitution, and advanced EM instrumentation.
- Demands cross-team standardization of fixation and labeling protocols for reproducibility.
- Adaptation to tissue samples and diverse model systems may require further optimization.
- Tag sensitivity to aldehyde fixatives necessitates careful protocol adherence to preserve activity.
